According to Moderna 's latest financial reports the company's total debt is $1.24 B. A companyโs total debt is the sum of all current and non-current debts.
Year | Total debt | Change |
---|---|---|
2023-12-31 | $1.24 B | 3.58% |
2022-12-31 | $1.20 B | 31% |
2021-12-31 | $0.91 B | 286.5% |
2020-12-31 | $0.23 B | 79.05% |
2019-12-31 | $0.13 B | 295.25% |
2018-12-31 | $33.48 M | 113.48% |
2017-12-31 | $15.68 M | 25.5% |
2016-12-31 | $12.5 M |
Company | Total debt | differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $29.33 B | 2,259.77% | ๐บ๐ธ USA |
Novartis NVS | $26.34 B | 2,019.71% | ๐จ๐ญ Switzerland |
Merck MRK | $35.05 B | 2,720.19% | ๐บ๐ธ USA |
Regulus Therapeutics RGLS | $3.36 M | -99.73% | ๐บ๐ธ USA |
Dicerna Pharmaceuticals DRNA | N/A | N/A | ๐บ๐ธ USA |
Athersys ATHX | $18.57 M | -98.51% | ๐บ๐ธ USA |
Alnylam Pharmaceuticals
ALNY | $1.30 B | 5.02% | ๐บ๐ธ USA |
Arrowhead Pharmaceuticals
ARWR | $0.11 B | -90.46% | ๐บ๐ธ USA |